ASTELLAS PHARMA INC.

Business Segments Astellas Pharma Inc. OTC Markets

Stocks

ALPMY

US04623U1025

Pharmaceuticals

Market Closed - OTC Markets 15:59:59 2026-08-21 EDT			5-day change	1st Jan Change
15.04 ^USD	+0.53%		+2.17%	+13.17%

08-17	CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target	MT
08-10	AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge	RE

Sales 2026 by Business Segment

© MarketScreener.com See more

Sales 2026 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (JPY)

Fiscal Period: March	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Pharmaceutical Products
Pharmaceutical						1,296B	1,519B	1,604B	1,912B	2,139B
Total Assets						2,332B	2,457B	3,570B	3,340B	3,567B
Interest Expense						-2.32B	-3.22B	-7.42B	-13.95B	-10.32B
Income Tax Expense						32.8B	33.65B	7.92B	-19.51B	85.01B
CAPEX						-76.45B	-88.54B	-38.06B	-37B	-57.72B
EBT						157B	132B	24.97B	31.24B	377B
Gross Profit						1,043B	1,230B	1,311B	1,563B	1,731B
D&A						79.68B	106B	158B	199B	195B
Operating Income						220B	285B	178B	256B	420B

Geographical Revenue Distribution History

Geographical breakdown of sales (JPY)

Fiscal Period: March	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
USA						544B	658B	669B	872B	946B
Total Assets						675B	711B	1,734B	1,447B	1,354B
Others						483B	576B	649B	760B	876B
Total Assets						110B	118B	124B	147B	126B
Japan						269B	285B	286B	280B	317B
Total Assets						410B	349B	308B	274B	316B
Europe, Middle East and Africa (EMEA)						-	-	-	-	-
Total Assets						-	-	-	-	-
America Excluding United States of America						-	-	-	-	-
Total Assets						-	-	-	-	-
Asia and Oceania						-	-	-	-	-
Total Assets						-	-	-	-	-

As early as today, start finding the best investment opportunities!